EQ 300 - Zyvex Pharmaceuticals
EQ 300 (Boldenone Undecylenate) - Zyvex Pharmaceuticals Overview
EQ 300 by Zyvex Pharmaceuticals contains Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial - the standard concentration for Equipoise-type compounds used in bodybuilding cycles. Boldenone Undecylenate is a modified testosterone molecule - structurally, it is testosterone with an extra double bond at the 1-2 carbon position. This modification reduces the compound's rate of aromatization to approximately 50% of testosterone and eliminates the progestogenic activity seen in Nandrolone-based compounds. The undecylenate ester is one of the longest available, giving EQ 300 a half-life of approximately 14 days and an active life of roughly 3-4 weeks after a single injection. At 300 mg/ml, each 1 ml injection delivers 300 mg of Boldenone Undecylenate. The 10 ml vial contains 3,000 mg total - enough for a full 10-week cycle at 300 mg/week.
EQ 300 is known for producing steady, lean, quality mass gains with minimal water retention - a profile that distinguishes it from testosterone, which produces more dramatic but wetter gains. The tradeoff is time: the long undecylenate ester means cycles shorter than 12 weeks do not allow the compound to fully build up to effective blood levels and then produce meaningful results before the cycle ends. Experienced users run EQ 300 at 12-16 weeks as the cornerstone of a lean bulking stack, typically alongside Testosterone Enanthate or Cypionate as a base. The compound is not hepatotoxic - no 17-alpha-alkylation means liver monitoring requirements are minimal compared to oral anabolics.
About the Compound: Boldenone Undecylenate 300 mg/ml
Boldenone is a naturally occurring anabolic steroid found in trace amounts in cattle - it is the only naturally occurring anabolic steroid besides testosterone. The undecylenate ester, attached to the boldenone base to create the injectable form used in bodybuilding, is an 11-carbon chain ester and one of the longest available. This ester length is responsible for the ~14-day half-life and the correspondingly slow build-up and clearance of the compound. Full saturation of blood levels takes approximately 4-5 weeks after starting EQ 300 at a consistent weekly dose - which is why cycles under 12 weeks are suboptimal and cycles of 14-16 weeks are preferred by experienced users.
The structural modification of boldenone - the extra double bond at C1-C2 - produces two important differences from testosterone. First, it reduces aromatization to estrogen to approximately 50% of testosterone's rate, which means significantly less water retention and lower gynecomastia risk at equivalent weekly doses. Second, it eliminates progestogenic activity entirely. Boldenone does not bind progesterone receptors. This is a critical distinction from Nandrolone (Deca/NPP) - EQ does not cause the prolactin-mediated side effects associated with Nandrolone, and Cabergoline is never required on an EQ cycle.
EQ 300 vs EQ 500: Which Concentration to Choose
EQ 300 and EQ 500 contain identical active substance - Boldenone Undecylenate - and produce completely identical effects at matched weekly doses. The only difference is concentration per milliliter. At 300 mg/ml, EQ 300 requires more volume per injection to hit a given dose but is generally more comfortable to inject - lower concentration oils produce less post-injection pain (PIP) at most sites. At 500 mg/ml, EQ 500 requires less volume to hit the same dose, which is practical at higher doses (400-500 mg/week), but higher concentration oils are more prone to PIP, particularly in smaller injection sites like the deltoid.
| Weekly Dose | Volume with EQ 300 (300 mg/ml) | Volume with EQ 500 (500 mg/ml) | Best Format |
|---|---|---|---|
| 300 mg/week | 1 ml total (0.5 ml x2) | 0.6 ml total (0.3 ml x2) | EQ 300 (more comfortable) |
| 400 mg/week | 1.33 ml total (0.67 ml x2) | 0.8 ml total (0.4 ml x2) | Either |
| 500 mg/week | 1.67 ml total (0.83 ml x2) | 1 ml total (0.5 ml x2) | EQ 500 (convenient) |
| 600 mg/week | 2 ml total (1 ml x2) | 1.2 ml total (0.6 ml x2) | EQ 500 (lower injection volume) |
For users running 300-400 mg/week, EQ 300 is the more comfortable choice. For users running 500 mg/week or above who want to minimize injection volume, EQ 500 is more practical. The physiological effects are identical at matched doses.
What EQ 300 Does
Boldenone Undecylenate produces a distinct effect profile that separates it from both testosterone and Nandrolone - the other two dominant base compounds in injectable cycles. The gains are lean, dry, and relatively slow to accumulate compared to testosterone, but they are of higher quality and better retained post-cycle.
- Lean, quality mass gains - EQ 300 stimulates protein synthesis and nitrogen retention, but with significantly less water retention than testosterone due to its lower aromatization rate. The mass gained on an EQ cycle is drier and more aesthetically pleasing in-cycle than equivalent testosterone gains. Total mass accumulation is slower - typical EQ cycles produce 8-12 lbs of lean mass over 14-16 weeks at 400-500 mg/week, less than a comparable testosterone cycle, but a larger proportion of it is retained post-cycle because it is not water-dependent.
- Appetite stimulation - One of Boldenone's most distinctive and well-known effects is a significant increase in appetite. Users commonly report dramatically increased hunger within 2-3 weeks of starting EQ 300 - a characteristic that makes the compound particularly effective during bulking phases where high caloric intake is the goal. This appetite effect is more pronounced than that of testosterone and is a consistent user-reported finding across experience levels. For users who struggle to eat enough on a bulk, this is a practical advantage.
- Endurance and red blood cell production - EQ 300 is particularly effective at stimulating erythropoiesis (red blood cell production). More than testosterone at equivalent doses, Boldenone increases hematocrit and red blood cell count. The result is improved oxygen delivery to working muscle, enhanced endurance capacity, reduced fatigue during high-volume training, and faster removal of metabolic waste products. This effect also makes EQ 300 popular with athletes in endurance sports and with bodybuilders who do high-volume training.
- Vascularity - The combination of lean, water-free mass accumulation and increased red blood cell volume produces pronounced vascularity in EQ cycles. Users commonly report visible increases in vascular definition - particularly in the forearms, arms, and shoulders - as the cycle progresses. This makes EQ 300 a popular choice for lean bulk phases where aesthetics during the cycle matter alongside the mass-building goal.
EQ does NOT require prolactin management: Boldenone Undecylenate is not a progestin and does not bind progesterone receptors. This distinguishes it from Nandrolone (Deca 300, Deca 500, NPP) where prolactin elevation and the requirement for Cabergoline is a real concern. EQ cycles do not require Cabergoline. What EQ does require is an aromatase inhibitor on-cycle (at lower dose than testosterone cycles) and a testosterone base to maintain physiological function while endogenous production is suppressed.
Dosing and Cycle Protocols
| Experience Level | Weekly Dose | Injection Schedule | Cycle Length | Notes |
|---|---|---|---|---|
| Beginner / First EQ | 300-400 mg/week | 2x per week (e.g., Mon + Thu) | 12-14 weeks | Stack with Testosterone Enanthate or Cypionate 300-400 mg/week as base. Anastrozole 0.25 mg every other day. No Cabergoline needed. |
| Intermediate | 400-500 mg/week | 2x per week | 14-16 weeks | Lean bulk stack: EQ 400-500 mg/week + Test 400 mg/week. Can add Anavar 50 mg/day for the final 6-8 weeks as a finishing compound for dry, hard gains. |
| Advanced | 500-600 mg/week | 2x per week | 16 weeks | Full lean bulk: EQ 500-600 mg/week + Test 400-500 mg/week. Bloodwork at weeks 6-8 to check hematocrit - donate blood if hematocrit exceeds 52%. |
EQ 300 must always be run with a testosterone base at minimum 200 mg/week. Boldenone suppresses natural testosterone production. Running EQ without testosterone produces low-T symptoms (fatigue, low libido, mood decline) that worsen through the cycle as endogenous production approaches zero. The testosterone base maintains physiological function while Boldenone provides the primary anabolic drive.
Side Effects and Management
| Side Effect | Background | Management |
|---|---|---|
| Elevated hematocrit (red blood cell excess) | EQ 300's most clinically significant side effect. Boldenone is a particularly potent stimulator of red blood cell production - more so than testosterone at equivalent doses. Hematocrit can rise substantially over a 12-16 week cycle, increasing blood viscosity and cardiovascular risk (hypertension, clotting, stroke). This is the side effect most requiring active monitoring on EQ cycles. | Bloodwork every 6-8 weeks on-cycle to check hematocrit. If hematocrit exceeds 52%, donate blood to reduce red blood cell mass. Therapeutic phlebotomy (250-500 ml) is effective and brings hematocrit down within days. Stay well-hydrated throughout the cycle - dehydration concentrates blood and worsens the hematocrit picture. |
| Estrogen-related effects (mild) | Boldenone aromatizes to estradiol at approximately 50% the rate of testosterone. At typical EQ doses (300-500 mg/week), estrogen elevation is moderate compared to a testosterone cycle of equivalent dose. Water retention is minimal, and gynecomastia risk - while present - is lower than with testosterone. The issue compounds when running EQ alongside a testosterone base: combined aromatization from both compounds adds up. | AI at a lower dose than a testosterone-only cycle: Anastrozole 0.25 mg every other day or Exemestane 12.5 mg every other day is typically sufficient. Monitor symptoms and adjust based on bloodwork. Do not over-suppress estrogen. |
| HPTA suppression | EQ suppresses LH and FSH from the first injection, shutting down endogenous testosterone production. The very long half-life means suppression persists for several weeks after the last injection - longer than with short-ester compounds. Always run with a testosterone base to avoid low-T symptoms during the cycle. | Testosterone base (minimum 200 mg/week) throughout the entire cycle. Begin PCT 21 days after the last EQ injection to allow adequate clearance given the 14-day half-life. |
| Androgenic effects (acne, hair loss) | EQ has a moderate androgenic rating (~50 vs testosterone's 100). Androgenic side effects are generally less pronounced than with testosterone at matched doses, but acne and oily skin still occur at higher EQ doses in sensitive individuals. Hair loss risk in genetically predisposed users is present but less severe than with testosterone or Trenbolone. | Topical treatments for acne. Keep injection sites clean. Note: Finasteride is not effective for EQ androgenic effects - Boldenone does not convert to DHT via 5-alpha-reductase to the same degree as testosterone, so 5-AR inhibitors provide minimal protection. |
| Blood pressure | Elevated blood pressure on EQ cycles is driven primarily by the hematocrit increase (thicker blood requiring more cardiac work) rather than by water retention. Because EQ produces less water retention than testosterone, blood pressure from estrogen-driven volume expansion is less of an issue. The hematocrit-driven blood pressure elevation is the primary concern. | Monitor blood pressure weekly. Donate blood if hematocrit is elevated. Stay hydrated. Address any AI-related estrogen imbalance through bloodwork-guided adjustment rather than by adding antihypertensives as the first step. |
Post-Cycle Therapy
The 14-day half-life of Boldenone Undecylenate requires a longer wait before starting PCT than shorter-ester compounds. After the last injection of EQ 300, the compound remains active in the bloodstream for approximately 3-4 weeks. Starting PCT while active Boldenone is still circulating is counterproductive - it continues to suppress the HPTA while the SERM attempts to restart it. Wait 21 days after the last EQ 300 injection before starting PCT. When EQ is run alongside Testosterone Enanthate or Cypionate (as it almost always is), PCT timing is set by whichever compound has the longer clearance requirement - in practice both have similar timing, so the 21-day wait covers both.
| PCT Protocol | Drugs and Doses | Duration |
|---|---|---|
| Standard (EQ + Test cycle) | Clomid 50 mg/day, or Nolvadex 20 mg/day. Either alone is adequate for a standard 12-14 week EQ cycle. Both together (Clomid 50 mg + Nolvadex 20 mg daily) for more aggressive recovery after a 16-week cycle. | 4 weeks. Start 21 days after the last EQ 300 injection. |
| Long cycle (16+ weeks) | Clomid 100 mg/day for weeks 1-2, then 50 mg/day for weeks 3-4. Nolvadex 20 mg/day throughout all 4-6 weeks. | 4-6 weeks. Confirm recovery with bloodwork (LH, FSH, total testosterone, free testosterone) 4-6 weeks post-PCT. Also confirm hematocrit has normalized before next cycle. |
Frequently Asked Questions
What is EQ 300 and what does it contain?
EQ 300 by Zyvex Pharmaceuticals contains Boldenone Undecylenate at 300 mg per milliliter in a 10 ml multi-dose vial, for 3,000 mg total. "EQ" is shorthand derived from Equipoise, the original Squibb veterinary brand name for Boldenone Undecylenate. Boldenone is a modified testosterone molecule - structurally identical to testosterone except for an additional double bond at the C1-C2 position. This modification reduces its aromatization rate to approximately 50% of testosterone and eliminates progestogenic activity entirely. The undecylenate ester (11 carbons) gives EQ 300 a half-life of approximately 14 days - one of the longest half-lives of any injectable ester commonly used in bodybuilding. EQ 300 is not hepatotoxic (no 17-alpha-alkylation), making it suitable for 12-16 week cycles that would not be appropriate for oral anabolics. Known primarily for lean, dry mass gains, significant appetite stimulation, and a pronounced increase in endurance through red blood cell production.
What is the difference between EQ 300 and EQ 500?
EQ 300 and EQ 500 contain the same active compound - Boldenone Undecylenate - at different concentrations: 300 mg/ml versus 500 mg/ml. At matched weekly doses, the physiological effects are completely identical. The practical difference is injection volume and injection comfort. EQ 300 at 300 mg/week requires 1 ml per week total (two 0.5 ml injections). EQ 500 at 300 mg/week requires 0.6 ml per week total. Lower concentration oils like EQ 300 are generally more comfortable to inject with less post-injection pain (PIP) - higher concentration oils are more prone to local irritation, particularly in smaller injection sites. EQ 300 is the better choice for users running 300-400 mg/week who want comfortable injections. EQ 500 becomes practical at 500 mg/week and above, where keeping injection volumes low is desirable. If you are running 500 mg/week with EQ 300, each twice-weekly injection is 0.83 ml - entirely manageable, but EQ 500 cuts that to 0.5 ml per injection.
Why do EQ cycles need to be at least 12 weeks?
The minimum 12-week cycle length for EQ 300 is a direct consequence of the undecylenate ester's 14-day half-life. Because the compound releases slowly, it takes approximately 4-5 weeks from the first injection to reach stable, saturated blood levels where peak anabolic effects are being produced. A 6-8 week cycle would spend nearly half its duration in the build-up phase and would then need to end just as the compound is hitting peak effectiveness. Running EQ for less than 12 weeks is not cost-effective and produces results significantly below what the compound is capable of. Conversely, the slow build-up and long saturation period mean the benefits continue accumulating well into weeks 10-16, which is why longer cycles (14-16 weeks) are preferred by experienced users over shorter ones. This is the fundamental trade-off of long-ester compounds: slower onset requires planning for a longer runway, but the steady, stable blood levels over many weeks produce consistent and well-tolerated results.
Does EQ 300 significantly increase appetite?
Yes - appetite stimulation is one of the most consistently reported and distinctive effects of Boldenone Undecylenate. Users typically begin noticing a significant increase in hunger within 2-4 weeks of starting EQ 300. The mechanism is not fully understood but is well-established empirically - Boldenone's appetite-stimulating effect is more pronounced than testosterone's and is a characteristic that sets EQ apart from most other injectable anabolics. For users in a caloric surplus phase (bulking), this is a significant practical advantage: achieving the high caloric intake required for maximum mass gains becomes easier when appetite is noticeably elevated. For users who are not intentionally eating in a surplus, the appetite increase can become uncomfortable if food intake is not managed. Appetite returns to baseline after the compound clears, typically within 2-3 weeks of the last injection.
Does EQ 300 require Cabergoline or prolactin management?
No - EQ 300 does not require Cabergoline or any prolactin management. Boldenone Undecylenate is not a progestin and does not bind progesterone receptors. This is a fundamental pharmacological difference from Nandrolone-based compounds (Deca, NPP), where the progesterone receptor activity contributes to prolactin elevation and the associated side effects (lactation, sexual dysfunction). Users familiar with Deca or NPP cycles who add Cabergoline as a precaution do not need to do so when substituting or adding EQ 300. What EQ does require is an aromatase inhibitor on-cycle (at a lower dose than a testosterone-only cycle since EQ's aromatization rate is approximately half that of testosterone) and a testosterone base to maintain physiological testosterone levels while natural production is suppressed.
Does EQ 300 cause significant water retention?
No - water retention is one of EQ 300's defining advantages over testosterone. Because Boldenone aromatizes to estrogen at approximately 50% the rate of testosterone, the estrogen-driven water retention that is typical of testosterone cycles is substantially reduced on EQ. The gains from EQ 300 are lean and dry - more visible and aesthetically defined during the cycle than the bloated appearance common with high-dose testosterone cycles. Blood pressure elevation from estrogen-driven blood volume expansion is correspondingly lower. What does increase on EQ is hematocrit - the compound's potent red blood cell stimulation can substantially raise blood viscosity over a long cycle, which is the primary cardiovascular concern on EQ rather than water retention. An aromatase inhibitor is still required on EQ cycles (especially when run alongside a testosterone base), but the dose is typically lower than in testosterone-only cycles.
How long is Boldenone Undecylenate detectable on a drug test?
Boldenone Undecylenate has one of the longest detection windows of any commonly used anabolic steroid: approximately 4-5 months in urine testing under standard sports drug testing panels. This long detection window is a direct consequence of the 11-carbon undecylenate ester - longer esters release and clear more slowly, and boldenone metabolites persist in urine for an extended period after the last injection. Some sources report detection as long as 6 months in certain testing methodologies. For athletes subject to WADA-based drug testing or any anti-doping program, EQ 300 is one of the most problematic compounds from a clearance standpoint. The detection window for hair follicle testing is longer still - up to 12 months or more depending on hair length and growth rate. Natural boldenone also occurs at trace levels in food animals, which has historically created some false positive challenges in sports testing programs, but the levels from injectable use are far above any dietary threshold.
When do I start PCT after EQ 300?
Wait 21 days after the last injection of EQ 300 before starting PCT. This is longer than the 14-day wait for Testosterone Enanthate or Cypionate because the undecylenate ester has a half-life of approximately 14 days - two half-lives of clearance time is needed before PCT can work effectively against natural HPTA suppression. Starting PCT too early, while active Boldenone is still suppressing LH and FSH, is counterproductive. In practice, most EQ cycles are run alongside Testosterone Enanthate or Cypionate as a base, and the PCT wait covers both compounds at 21 days. PCT protocol after a standard EQ + Test cycle: Clomid 50 mg/day for 4 weeks, or Nolvadex 20 mg/day for 4 weeks, or both together (Clomid 50 mg + Nolvadex 20 mg daily) after longer cycles. After a 16-week cycle: Clomid 100 mg/day for weeks 1-2 then 50 mg/day for weeks 3-4, plus Nolvadex 20 mg/day throughout. Also confirm hematocrit has returned to normal range on post-cycle bloodwork before planning the next cycle.
Related Products
- Promotes steady lean muscle growth and strength.
- Enhances endurance via increased red blood cell production.
- Supports fat loss for a defined physique.
- Delivers high-quality gains with minimal water retention.
- Promotes lean muscle growth and strength.
- Enhances endurance and recovery.
- Supports fat loss with minimal water retention.
- Delivers sustained anabolic effects.
- Promotes steady lean muscle growth and strength.
- Enhances endurance via increased red blood cell production.
- Supports fat loss for a defined physique.
- Delivers high-quality gains with minimal water retention.